代谢综合征合并慢性心房纤颤患者抗凝血药治疗依从性及影响因素分析

The level and influencing factors of the anticoagulants treatment adherence in patients with metabolic syndrome combined chronic atrial fibrillation / WANG Wei- jv

目的了解代谢综合征合并慢性心房纤颤患者口服抗凝血药物的依从性并分析影响因素。方法采用自制抗凝血药物知识问卷、抗凝血药物治疗依从性调查表,对82例符合诊断标准的门诊患者进行问卷调查,并进行12周随访。结果患者抗凝知识问卷总均分为(11.39±5.33)分,抗凝血药物治疗依从性总均分为(15.12±3.87)分,患者抗凝血药物治疗的依从性和患者抗凝知识得分、既往病史、抗凝血药物种类、同时服用药物数量相关。结论代谢综合征合并慢性房颤患者口服抗凝血药物的依从性总体不佳,有利因素是既往血栓事件和较高的抗凝知识得分,不利因素是口服华法林抗凝、同时服用7种以上药物和既往出血病史,护理人员应采取针对性护理干预提高患者治疗依从性。

Objective To investigate the level and influencing factors of anticoagulants treatment adherence in patients with metabolic syndrome combined chronic atrial fibrillation. Methods Eighty - two outpatients with metabolic syndrome and chronic atrial fibrillation were investigated using a self - designed questionnaire,and were followed for 12 weeks. Results Average scores of anticoagulation knowledge and anticoagulant medication adherence were （ 11.39 ±5.33 ） and （15.12 ± 3.87 ）, respectively. The adherence was related to knowledge scores, medical history, types of anticoagulant drugs and numbers of all taking drugs. Conclusion The anticoagulants treatment adherence in patients with metabolic syndrome combined chronic atrial fibrillation is poor, positive factors are previous thrombotic events history and better knowledge points,negative factors are oral warfarin,previous bleeding history and more than 7 kinds taking drugs. Nursing staff should take targeted measures to improve the treatment adherence of patients.